Beyond market trends, investors keen on maximizing returns delve into the world of stock picking. The right selections can be instrumental in catapulting your wealth.
As of close of business last night, Phathom Pharmaceuticals Inc’s stock clocked out at $7.74, up 5.59% from its previous closing price of $7.33. In other words, the price has increased by $5.59 from its previous closing price. On the day, 0.8 million shares were traded. PHAT stock price reached its highest trading level at $7.79 during the session, while it also had its lowest trading level at $7.34.
Ratios:
To gain a deeper understanding of PHAT’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 5.68 and its Current Ratio is at 5.73.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Stifel on May 03, 2024, initiated with a Buy rating and assigned the stock a target price of $24.
On January 05, 2024, Needham reiterated its Buy rating and also lowered its target price recommendation from $23 to $26.
On August 09, 2023, H.C. Wainwright started tracking the stock assigning a Buy rating and target price of $28.H.C. Wainwright initiated its Buy rating on August 09, 2023, with a $28 target price.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Dec 19 ’24 when Nabulsi Azmi sold 1,118 shares for $8.00 per share. The transaction valued at 8,944 led to the insider holds 239,303 shares of the business.
Henderson Molly sold 1,291 shares of PHAT for $10,328 on Dec 19 ’24. The CFO and CBO now owns 98,156 shares after completing the transaction at $8.00 per share. On Dec 13 ’24, another insider, KARBE FRANK, who serves as the Director of the company, bought 12,500 shares for $7.93 each. As a result, the insider paid 99,084 and bolstered with 57,000 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, PHAT now has a Market Capitalization of 529241056 and an Enterprise Value of 713554752. For the stock, the TTM Price-to-Sale (P/S) ratio is 21.27. Its current Enterprise Value per Revenue stands at 27.162 whereas that against EBITDA is -2.485.
Stock Price History:
Over the past 52 weeks, PHAT has reached a high of $19.71, while it has fallen to a 52-week low of $6.07. The 50-Day Moving Average of the stock is -29.32%, while the 200-Day Moving Average is calculated to be -36.11%.
Shares Statistics:
It appears that PHAT traded 1.29M shares on average per day over the past three months and 1064630 shares per day over the past ten days. A total of 68.32M shares are outstanding, with a floating share count of 34.87M. Insiders hold about 49.01% of the company’s shares, while institutions hold 68.83% stake in the company. Shares short for PHAT as of 1734048000 were 14131833 with a Short Ratio of 10.98, compared to 1731628800 on 14663729. Therefore, it implies a Short% of Shares Outstanding of 14131833 and a Short% of Float of 29.17.
